BKYIIndustrials · Security & Protection ServicesThe 1 Wall Street analysts covering BIO-key International, Inc. hold a median 12-month price target of $20 — +1049.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 39 of 100 as at 8 Oct 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores BIO-key International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (98): Smaller than most of the companies we track.
Issuance (11): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on BKYI, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +1049.4% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 Mar 2021 | Maxim Group | Upgrade | Buy | $6.00 |
| 25 Nov 2020 | Maxim Group | Downgrade | Hold | — |
| 4 Oct 2019 | Maxim Group | Downgrade | Hold | — |
| 16 Aug 2018 | Maxim Group | Maintains | Buy | $5.50 → $5.00 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BKYI appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 8 Oct 2026, BIO-key International, Inc. returned −76.8% against +16.2% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 79% of US stocks
Cheaper than 85% of US stocks
Cheaper than 85% of US stocks
Cheaper than 66% of US stocks
Higher than 59% of US stocks
Higher than 51% of US stocks
Higher than 95% of US stocks
Higher than 20% of US stocks
Higher than 6% of US stocks
Higher than 12% of US stocks
Higher than 17% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
BIO-key International, Inc. has a market value of $2.6M and an enterprise value of $2.1M.
Revenue in the twelve months to 30 June 2026: $6.7M. The latest quarter grew 13.1% year on year.
Net income over the same four quarters: −$6.0M, a −90.1% net margin.
Diluted earnings per share, trailing twelve months: $−4.11.
Free cash flow in the twelve months to 30 June 2026: −$4.2M, after $6K of capital spending.
Trailing P/E: −0.3×; forward P/E: 8.3× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
BIO-key International, Inc. employs 41 people — $163K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own BIO-key International, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
BIO-key (BKYI) announced a partnership with Al Majlis Group, founded by His Excellency Dherar Belhoul Al Falasi, to expand its identity security business across the Arabian Gulf region.
Why it matters — The partnership could open new regional market opportunities for BIO-key's identity security solutions through a locally connected partner in the Gulf.
BIO-key announced that its Passkey:YOU authentication product has received Full Certification from the FIDO Alliance, the industry body behind the FIDO2/WebAuthn/Passkey standard. The company said this certification unlocks new markets, including agentic AI authenticated controls.
Why it matters — Full FIDO Alliance certification could broaden the market reach of BIO-key's authentication offering and strengthen its competitive standing in the identity and access management space.
BIO-key International announced that its CEO, Michael DePasquale, will be available for virtual meetings at the H.C. Wainwright Global Investment Conference. The announcement was made via GlobeNewswire on September 1, 2026.
Why it matters — A BKYI watcher would care because the CEO's participation at a major investment conference gives the company an opportunity to present its identity and access management business to investors and potential partners.
BIO-key International held its Q2 2026 earnings call, and Seeking Alpha published a transcript of the event.
Why it matters — The earnings call transcript provides BKYI watchers with management's detailed discussion of the company's financial results and operational performance for the quarter.
BIO-key International reported a 13% rise in second-quarter revenues and a 51% improvement in its bottom line, driven by strength with government, defense, and financial sector customers globally. The company also announced an upcoming earnings call at 10am ET.
Why it matters — A BKYI watcher would care because the company's revenue growth and significantly improved bottom line suggest strengthening demand from key institutional sectors like government, defense, and finance.
The 1 Wall Street analysts covering BIO-key International, Inc. have a median 12-month price target of $20, with estimates ranging from $20 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 1 analysts covering BIO-key International, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks BIO-key International, Inc. 39 out of 100 across roughly 4,600 US stocks as at 8 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 8 Oct 2026, BIO-key International, Inc. ranks 39 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (98 of 100).
No one can know that. What the data says: the median 12-month target from 1 analysts implies +1049.4% from the last close, and Ticker Nerd's factor model ranks BIO-key International, Inc. 39 out of 100 as at 8 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering BIO-key International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BKYI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $20 to $20 over the next 12 months.
BIO-key International, Inc. returned -76.8% over the 12 months to 8 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
BIO-key International, Inc. is a biometrics and identity access management company that develops fingerprint authentication and secure access software for organizations.
The most recent item we track (GlobeNewsWire, 29 Sept 2026): "BIO-key Partners with Al Majlis Group to Expand Identity Security Across Arabian Gulf". BIO-key (BKYI) announced a partnership with Al Majlis Group, founded by His Excellency Dherar Belhoul Al Falasi, to expand its identity security business across the Arabian Gulf region.
BIO-key International, Inc. is a biometrics and identity access management company that develops fingerprint authentication and secure access software for organizations. BIO-key International, Inc. offers cloud-based and on-premise identity platforms, including PortalGuard and PortalGuard IDaaS, to support multi-factor authentication, single sign-on, passwordless login, privilege access control, and user provisioning. Its product portfolio also includes biometric identity verification tools, civil and large-scale identification systems, mobile authentication applications, and fingerprint readers for enterprise use. The company serves commercial, government, and education customers across industries that require secure workforce, student, citizen, and customer access management. Headquartered in Holmdel, New Jersey, and founded in 1993, BIO-key International, Inc. focuses on combining biometric hardware and software to simplify digital identity security and reduce reliance on traditional credentials.
CEO Mr. Michael W. DePasquale · 41 employees · United States · https://www.bio-key.com
